Russell Investments Group
CODX

Russell Investments Group’s Co-Diagnostics CODX Stock Holding History

Russell Investments Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,074
Closed -$2.16M – 2778
2021
Q4 		$2.16M Sell
8,074
-3,033
-27% -$796K ﹤0.01% 1760
2021
Q3 		$3.24M Buy
11,107
+2,643
+31% +$771K 0.01% 1516
2021
Q2 		$2.09M Buy
8,464
+2,740
+48% +$704K ﹤0.01% 1889
2021
Q1 		$1.64M Buy
+5,724
New +$2.28M ﹤0.01% 1993

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Russell Investments Group's CODX Position: Q1 2022 in Review

Russell Investments Group sold out of Co-Diagnostics (CODX) in Q1 2022, closing a stake of 8,074 shares — an estimated $2.16M sold.

Russell Investments Group first reported a position in CODX in Q1 2021 and held it in 4 quarters. The position peaked at $3.24M in Q3 2021. 82 funds tracked by Wall St. Rank hold CODX as of Q1 2022.

  • Russell Investments Group reported no remaining Co-Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Russell Investments Group sold 8,074 Co-Diagnostics shares in Q1 2022, an estimated $2.16M.
  • Russell Investments Group first reported a position in Co-Diagnostics in Q1 2021 and held it in 4 quarters.
  • Russell Investments Group's Co-Diagnostics position peaked at $3.24M in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2022.

Based on Russell Investments Group's 13F filing for Q1 2022, filed 5 May 2022.